Dr. Kristen Fortney is CEO & cofounder of BIOAGE - a company working on slowing aging and chronic disease.
Figuring out how to live longer is an age-old problem. For as long as humans have studied medicine, we have tried to learn which remedies, habits, and environments best position us to have a chance of long life.
Recent developments in the last few decades have, for the first time in human history, opened up the door for serious progress into understanding how humans and animals age. Last season, we had Celine on the show to talk about the work that her team is doing to improve the health of dogs. Lessons that might one day be applied to humans.
Now, Kristen joins us to give us an overview of the aging field. She also shares how BIOAGE is using machine learning to develop a pipeline of therapeutic assets that increase healthspan & lifespan. Aging may be the core cause of many of the cancers and chronic diseases that wind up killing us. If we can leverage AI to help identify flawed genes, we can make lifespan truly malleable.
Plenty of exciting discussions ensue - including what the differences are between healthspan and lifespan, what it would take for the healthcare industry & regulatory bodies to approve anti aging drugs, and how we might otherwise learn how to live as long as 200 year old whales or 1000 year old trees.
Dr. Kristen Fortney is CEO & cofounder of BIOAGE - a company working on slowing aging and chronic disease.
Figuring out how to live longer is an age-old problem. For as long as humans have studied medicine, we have tried to learn which remedies, habits, and environments best position us to have a chance of long life.
Recent developments in the last few decades have, for the first time in human history, opened up the door for serious progress into understanding how humans and animals age. Last season, we had Celine on the show to talk about the work that her team is doing to improve the health of dogs. Lessons that might one day be applied to humans.
Now, Kristen joins us to give us an overview of the aging field. She also shares how BIOAGE is using machine learning to develop a pipeline of therapeutic assets that increase healthspan & lifespan. Aging may be the core cause of many of the cancers and chronic diseases that wind up killing us. If we can leverage AI to help identify flawed genes, we can make lifespan truly malleable.
Plenty of exciting discussions ensue - including what the differences are between healthspan and lifespan, what it would take for the healthcare industry & regulatory bodies to approve anti aging drugs, and how we might otherwise learn how to live as long as 200 year old whales or 1000 year old trees.
For full show notes, links, RSVPs to live podcast recordings and more, visit thedeepend.substack.com